Generic medicine

Teriparatide: Brands, Price & Uses in Bangladesh

Teriparatide is indicated for the treatment of osteoporosis in specific high-risk patient groups where the goal is to increase bone mass and reduce fracture risk.

Forms:SC Injection

About Teriparatide

Indications of Teriparatide

Teriparatide is indicated for the treatment of osteoporosis in specific high-risk patient groups where the goal is to increase bone mass and reduce fracture risk.

Established / FDA-Approved Uses

  • Treatment of osteoporosis in postmenopausal women at high risk of fracture, including those with a history of osteoporotic fracture, multiple risk factors for fracture, or who have failed or are intolerant to other osteoporosis therapies.
  • To increase bone mass in men with primary or hypogonadal osteoporosis at high risk of fracture.
  • Treatment of men and women with glucocorticoid-induced osteoporosis at high risk of fracture who are receiving sustained systemic glucocorticoid therapy.

Teriparatide is an anabolic (bone-forming) agent and is generally reserved for patients with severe osteoporosis or those who have not responded adequately to antiresorptive therapy, based on specialist assessment.

Dosage & Administration of Teriparatide

Adult Dose

IndicationDose
Osteoporosis in postmenopausal women, men, and glucocorticoid-induced osteoporosis20 micrograms (mcg) subcutaneously once daily, injected into the thigh or abdominal wall

Administration

Teriparatide is administered as a subcutaneous injection using a pre-filled pen, typically self-administered by the patient at approximately the same time each day. The first one or more doses should be given where the patient can sit or lie down, in case of orthostatic hypotension. Rotate injection sites and follow the specific pen device instructions provided with the product.

Renal Impairment

Use with caution in patients with moderate renal impairment; not recommended in patients with severe renal impairment due to limited data.

Hepatic Impairment

No specific dose adjustment has been established; use with caution.

Side Effects of Teriparatide

Common side effects associated with Teriparatide include:

  • Nausea
  • Leg cramps
  • Dizziness
  • Headache
  • Injection site pain, redness, or irritation
  • Arthralgia (joint pain)
  • Mild, transient elevations in serum calcium

Less common but clinically important effects include transient orthostatic hypotension shortly after dosing (see Precautions) and hypercalcemia. Seek prompt medical attention for signs of a severe allergic reaction (rash, swelling of the face or throat, severe dizziness, difficulty breathing).

Contraindications of Teriparatide

Teriparatide is contraindicated in patients with known hypersensitivity to Teriparatide or any component of the formulation, and in patients with conditions associated with an increased baseline risk of osteosarcoma or other malignant bone conditions, including:

  • Paget's disease of bone
  • Unexplained elevations of serum alkaline phosphatase
  • Open epiphyses (pediatric and young adult patients with open growth plates)
  • Prior external beam or implant radiation therapy involving the skeleton

It is also contraindicated in patients with:

  • Pre-existing hypercalcemia
  • Metabolic bone diseases other than osteoporosis (e.g., primary hyperparathyroidism)
  • Bone metastases or a history of skeletal malignancy

Frequently Asked Questions about Teriparatide

What is Teriparatide used for?

Teriparatide is used to treat osteoporosis in postmenopausal women and men at high risk of fracture, and in men and women with glucocorticoid-induced osteoporosis. It works by stimulating new bone formation.

How is Teriparatide given?

Teriparatide is given as a subcutaneous (under the skin) injection once daily, usually in the thigh or abdominal wall, using a pre-filled pen device.

How long can I use Teriparatide?

Teriparatide is used for a limited duration only. Lifetime cumulative exposure should not exceed the maximum duration specified in the product labeling (commonly up to 24 months), due to a bone cancer (osteosarcoma) signal seen in animal studies, which has not been confirmed in extensive human data. Your physician will advise on the exact duration appropriate for you.

Can Teriparatide cause bone cancer?

Teriparatide carries a historical warning about osteosarcoma (a type of bone cancer) based on findings in rodent studies at high doses; this has not been confirmed in extensive human post-marketing data. As a precaution, Teriparatide is not used in patients with conditions that already raise osteosarcoma risk, such as Paget's disease of bone, unexplained elevated alkaline phosphatase, open growth plates, or prior radiation therapy to the skeleton.

What should I do if I feel dizzy after my Teriparatide injection?

Some patients experience transient dizziness or lightheadedness (orthostatic hypotension) shortly after injection, especially with the first few doses. It is advisable to sit or lie down when injecting the first doses until you know how you respond. If dizziness persists or is severe, contact your physician.

Can Teriparatide be used during pregnancy?

Teriparatide is not intended for use in women who are or may become pregnant, and there is limited data on its use in pregnancy or breastfeeding. It should only be used in pregnancy or lactation if clearly needed and after consulting a physician, since the potential benefit must be weighed against potential risk to the fetus or infant.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles